Stock Ticker Symbol MEIP

Stock Ticker Symbol MEIP

MEI Pharma, Inc. stock is traded on the Nasdaq Stock Market under the ticker symbol MEIP. MEI Pharma, Inc. is in the Biotechnology & Medical Research industry.

MEI Pharma, Inc. is a clinical-stage pharmaceutical company, which is engaged in developing novel and differentiated cancer therapies. The Company’s drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and ME-344, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway. Voruciclib has completed a Phase I trial evaluating dose and schedule in patients with acute myeloid leukemia (AML) in combination with the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax (marketed as Venclexta). Voruciclib is also being evaluated in pre-clinical studies to explore potential activity in various solid tumor cancers including in combination with therapies that target the RAS signaling pathway, such as KRAS inhibitors. MEI-344 is a drug candidate that inhibits mitochondrial OXPHOS, a fundamental metabolic pathway involved in the production of adenosine triphosphate (ATP) in the mitochondria.

Stock Ticker Symbol Lookup
Here you can look up another stock ticker symbol.

Stock Ticker Symbol BTCS
Here is another stock ticker symbol that we have information about!